SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022658
Filing Date
2024-05-10
Accepted
2024-05-10 16:37:48
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20240331.htm   iXBRL 10-Q 653147
2 EX-10.6 a2024q1-exhibit106.htm EX-10.6 41701
3 EX-31.1 a2024q1-exhibit311.htm EX-31.1 12672
4 EX-31.2 a2024q1-exhibit312.htm EX-31.2 12665
5 EX-32.1 a2024q1-exhibit321.htm EX-32.1 6870
  Complete submission text file 0001628280-24-022658.txt   4190810

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20240331.xsd EX-101.SCH 33420
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20240331_cal.xml EX-101.CAL 49343
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20240331_def.xml EX-101.DEF 125942
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20240331_lab.xml EX-101.LAB 447903
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20240331_pre.xml EX-101.PRE 301386
63 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20240331_htm.xml XML 396961
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 24935570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)